GlaxoSmithKline to pay $3bn in US drug fraud scandal

Jul 05, 2012 by

GlaxoSmithKline to pay $3bn in US drug fraud scandal

GlaxoSmithKline GSK is to pay $3bn £1.9bn in the largest healthcare fraud settlement in US history. The drug giant is to plead guilty to promoting two drugs for unapproved uses and failing to report safety data about a diabetes drug to the Food and Drug Administration FDA. The settlement will cover criminal fines as well as civil settlements with the federal and state governments. The case concerns the drugs Paxil, Wellbutrin and Avandia. Deputy US Attorney General James Cole told a news conference in Washington DC that the settlement was “unprecedented in both size and scope”.

GlaxoSmithKline to pay $3bn in US drug fraud scandal

Other Posts You May Be Interested In

From around the web Tagged with: diabetesdiabetes drugFOODFood and Drug Administration FDAGlaxoSmithKlinescandalsettlementThe settlementUS drug fraud

About the author

Assistant Editor - Mindscape magazine.
Stop SOPA

Facebook

Twitter

Google Plus

Follow Me on Pinterest
  • More believe aliens than god.

    Pinned: 19 Oct 2012
  • Study recommends decriminilisation of drugs.

    Pinned: 15 Oct 2012
  • Life on moons easier to find?

    Pinned: 11 Oct 2012
  • Man falls to Earth from 23 miles up.

    Pinned: 9 Oct 2012
  • Simon Singh under attack for criticisng health magazine.

    Pinned: 4 Oct 2012
  • Jail time for another banker.

    Pinned: 22 Sep 2012
  • ATOS inhumane puppets of a sick government. This has to stop.

    Pinned: 22 Sep 2012
  • Strange rock on mars

    Pinned: 20 Sep 2012
  • Jesus said he was married

    Pinned: 19 Sep 2012
  • Bees reboot brain to accomplish different tasks.

    Pinned: 17 Sep 2012